Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Linezolid Intravenous Infusion I.P. 2mg Infusion
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Infusion
Packaging Type
vial
Packaging
300ml
Price
₹820/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Linzoglad IV Infusion contains Linezolid, a potent antibiotic in the oxazolidinone class, formulated for intravenous administration. It is effective against a wide range of serious Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Linezolid works by inhibiting bacterial protein synthesis, thus preventing bacterial growth. It is typically reserved for use in hospital settings, especially in patients who require intravenous therapy due to the severity of their infection or the inability to take oral antibiotics.
Common side effects include headache, diarrhea, nausea, and vomiting. Serious side effects may include thrombocytopenia, anemia, or serotonin syndrome, especially when used with other serotonergic agents.
Linzoglad IV Infusion is indicated for the treatment of severe infections caused by Gram-positive bacteria, such as pneumonia, skin and soft tissue infections, and VRE-associated infections.
Use under strict medical supervision. Prolonged use may lead to the development of drug-resistant bacteria.
Store in a cool, dry place below 25°C. Once reconstituted, the infusion should be used immediately or within a specified time frame as per the instructions.
Composition : Levofloxacin 500mg Infusion
Composition : Amikacin (100mg)
Composition : Amikacin (250mg)
Composition : Amikacin (500mg)
Composition : Ofloxacin I.P. 200mg + Sodium Chloride I.P. 900mg Infusion
Composition : Meropenem (1000mg) Injection
Composition : Meropenem (1000mg) + Sulbactam (500mg)
Composition : Meropenem (250mg)
Composition : Meropenem (500mg) Injection
Composition : Vancomycin (1000mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Linezolid IV infusion is a critical-care antibiotic used for serious hospital infections caused by resistant bacteria such as MRSA, pneumonia, sepsis, and complicated skin and soft tissue infections. It is a strong hospital-based injectable anti-infective segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from high-value institutional demand in hospitals, ICUs, and emergency care units. IV antibiotics are essential in inpatient care, ensuring consistent bulk procurement and repeat hospital orders in critical cases.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for critical-care and injectable anti-infective formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from ICU-level demand, hospital procurement contracts, emergency usage, and steady high-value institutional turnover when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical-care antibiotic infusion can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.